Gut-Lung Axis in COVID-19 | Zendy

Imane Allali | Zendy; Youssef Bakri | Zendy; Saaïd Amzazi | Zendy; Hassan Ghazal | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Gut-Lung Axis in COVID-19

Author(s) -

Imane Allali,

Youssef Bakri,

Saaïd Amzazi,

Hassan Ghazal

Publication year - 2021

Publication title -

interdisciplinary perspectives on infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.593

H-Index - 28

eISSN - 1687-7098

pISSN - 1687-708X

DOI - 10.1155/2021/6655380

Subject(s) - microbiome , lung , covid-19 , gut microbiome , medicine , immunology , immunity , respiratory system , coronavirus , host (biology) , pandemic , virology , biology , immune system , bioinformatics , pathology , disease , genetics , infectious disease (medical specialty)

COVID-19 is a pandemic infection of the respiratory system caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The viral ribonucleic acid (RNA) was found in many parts of the COVID-19 patients including the stool, suggesting a potential interaction with the host's gut microbiome. The gut microbiome also plays major roles in immunity and inflammation. It also impacts pulmonary functions through the gut-lung axis. There have been recent reports of the importance of the host microbiome in infection and pathogenicity. The understanding of the gut and lung microbiomes would open the gate to new therapeutic approaches.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research